Ileal and axillary metastases by primary melanoma in unknown site;Metastasi ileale ed ascellare da melanoma primitivo a sede ignota. Caso clinico

Annali Italiani di Chirurgia

Volumn 68, Issue 3, 1997, Pages 385-389

  Catania, V ^a   Bonaccorso, R ^a   Santuccio, A ^a   Pastorelli, F ^a   Baggieri, S ^a   Cavallaro, V ^a   Minutolo, V ^a   Cammisuli, F ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Ileum; Melanoma; Metastases

Indexed keywords

ARTICLE; AXILLA; CASE REPORT; FATALITY; HUMAN; ILEUM TUMOR; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; MIDDLE AGED; NEOPLASM; PATHOLOGY;

AXILLA; FATAL OUTCOME; HUMANS; ILEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY;

EID: 0031129448     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Avril M.F. et al.: Regression of primary melanoma with metastases. Cancer, 69:1377-1381, 1992.
2. Balch CM., Houghtron A., Peters L, Cutaneous melanoma. In: Cancer. Principles & pratice of oncology. 3rd Ed. ED. Lippmcott Company, Philadelphia 1989.
3. Bonadonna G.: Melanoma maligna cutaneo. In: Medicina oncologic. Ediz. Masson, 1994:605-614.
4. Branum G., Seiglerh F.: Role of surgical intervention in the management of intestinal metastases from malignant melanoma. Am J Surg, 162(4):428-431, 1991.
5. Buzaid A. et al.: Patients with local-regional recurrence of melanoma. Cancer, 1, Vol. 74, 9, 1994.
6. Caputy G et al.: Metastatic melanoma of the gastrointetinal tract - result of surgical management. Arch Surg, 126, nov., 1991.
7. Cattelan A et al.: Melanoma metastatico: induzione di una risposta clinica completa e duratura dopo trattamento con anticorpi antiidiotipo. Atti del XIX Congresso Nazionale «Terapie adiuvant, e neoadjuvanti in chirurgia oncologica». Firenze 2-4 novembre 1995.
8. Deisseroth A.B.: Newer methods of cancer treatment. In: Cancer. Principles & practice of onclogy. 3rd Ed. ED. Lippincott Company, Philadelphia 1989.
9. Doveil G.C., Bertero M., Fierro M.T. et al.: Interleuchina a basse dosi per via sottocutanea associata a chemioimmuno-ormono terapia nel trattamento del melanoma in stadio IV. In: Atti giornate di terapia in dermovenereologia, 1994:48-49.
10. Fierlbeck G. et al.: Intralesional therapy of melanoma metastases with recombinant interferon-beta. Hautarzt, 43(1): 16-21, 1992.
11. Fletcher W.S. et al.: Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest oncology group study. Am J Clin Oncol, 16(4):359-62, 1993.
12. Ghussen F., Nagel K., Groth W. et al.: A prospective randomizer study of regional extremity perfusion in pazients with malignant melanoma. Ann Surg, 200:764-770, 1984.
13. Hena M. et al.: Effect of surgical treatment on stage IV melanoma. Am J Surg, vol 153, March 1987.
14. Hirota T. et al.: Malignant melanoma with mesenteric metastasis causing an intrapelvic Abscess: report of a case. Surg Today; JPN J Surg, 25:451-454, 1995.
15. Khayat D., Borel C, Tourami J.M. et al.: Sequential chemioimmunotherapy with cisplatin, interleukin-2 and interferon alfa-2a for metastatic melanoma. J Clin Oncol, 11:2173-2180, 1993.
16. Khayat D. et al.: Chemioimmunotherapy of metastatic malignant melanoma. The Salpétrière hospital experience. Eur J Cancer, 29A, Suppl. 5:S2-S5, 1993.
17. Kirkwood J.M., Lotze M.T.: Melanoma. In: Current cancer therapeutics and current medicine, 1994 - Philadelphia-USA.
18. Lastoria S. et al.: Scintigrafia con analoghi della somatostatina marcati con Tc-99 in pazienti con melanoma. Atti del XIX congresso nazionale «Terapie adiuvanti e neoadiuvanti in chirurgia oncologica» Firenze 2-4 novembre 1995.
19. Mondini G. et al.: La perfusione ipertermico antiblastica nel trattamento del melanoma recidivo degli arti. Esperienza personale. Atti del XIX Congresso Nazionale «Terapie adiuvanti e neoadiuvanti in chirurgia oncologica» Firenze 2-4 Novembre 1995.
20. Merrouche Y. et al.: Clinical application of retroviral gene transfer in oncology: results of a french study with tumor-infitrating lymphocytes transduced with the gene of resistance to neomycin. J Clin Oncol, 13(2):410-8, 1995.
21. Norman J. et al.: Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg, vol 162, Nov. 1991.
22. Overgaard J. et al.: Randomised trial of hypertermia as adjuvant to radiotherapy over reccurent or metatastatic malignant melanoma. Lancet, 345(8949):540-3, 1995.
23. Reintgen D.S. et al.: Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Curr Surg, March-April: 87, 1984.
24. Ryan L., Kramar A., Borden E.: Prognostic factors in metastatic melanoma. Cancer, 71:2995-3005, 1993.
25. Sirott M.N. et al.: Prognostic factors in patients with metastatic malignant melanoma. Cancer, 72, 10, 1993.
26. Tartour E. et al.: Prognostic value of cytokine and soluble FC gamma receptor assay in oncology. Immunol Lett, 44(2-3): 145-8, 1995.